Table 2 Age-specific results of HPV genotyping by HPV carcinogenicity categories among women positive in HPV screening

From: Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland

 

PCR test

HPV classification a

 

Total

Negative

Any HPV

Group 1/2A b

Group 2B c

Group 3 d

Age group ( y)

n

n

% of HC2+

n

% of HC2+

n

% of HC2+

n

% of HC2+

n

% of HC2+

25

417

105

25.2

312

74.8

273

65.3

27

6.5

12

2.9

30

550

136

24.7

414

75.3

361

65.5

44

8.0

9

1.6

35

369

104

28.1

265

71.8

220

59.3

37

10.0

8

2.2

40

302

66

21.9

236

78.1

190

62.7

42

13.9

4

1.3

45

223

84

37.7

139

62.3

106

47.3

31

13.8

2

0.9

50

233

76

32.6

157

67.4

118

50.4

32

13.7

7

3.0

55

256

104

40.6

152

59.4

109

42.4

28

10.9

15

5.9

60

190

80

42.1

110

57.9

80

41.5

21

10.9

9

4.7

65

34

18

52.9

16

47.1

14

41.2

2

5.9

0

−

Total

2 574

773

30.0

1 801

70.0

1 471

57.1

264

10.3

66

2.6

  1. aOn the basis of the classification of carcinogens to humans by the International Agency for Research on Cancer (IARC), Group 2B including HPV 73 in the current study.
  2. bInfection with one ore more Group1/2A type (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68), coinfection with HPV types of Group 2B and / or Group 3 allowed.
  3. cInfection with one or more Group 2B HPV type (26, 30, 53, 66, 67, 69, 70, 73 and 82), coinfection with HPV types of Group 3 allowed.
  4. dInfection with one or more Group 3 HPV type (6, 7, 9, 11, 40, 42, 43, 61, 74, 81, 83, 86, 87, 89, 90, 91 and 114).
Back to article page